BioRestorative Therapies (BRTX) Common Equity (2010 - 2025)
BioRestorative Therapies (BRTX) recorded Common Equity of $356,744 in Q4 2025, down 95.8% from $8.53 million a year earlier and down 83.8% from the prior quarter.
Powered by 
Analysis
BioRestorative Therapies (BRTX) Common Equity (2010 - 2025) Analysis & Trends
Starting with Q4 2010, BioRestorative Therapies' Common Equity history includes 59 quarters.
- Annual Common Equity has declined for four straight years.
- Across earlier years, Common Equity came in at $8.53 million in FY2024 (-14.7%), $10 million in FY2023 (-2.8%), $10.29 million in FY2022 (-4.6%) and $10.78 million in FY2021.
- The Q4 2025 figure is the lowest quarterly Common Equity since Q3 2021.
- On a year-over-year basis, Common Equity has declined for six consecutive quarters, with growth averaging 15.6% over the last eight quarters.
- Peak year-over-year performance for Common Equity in the last five years was growth of 308.3% in Q2 2024, against a decline of 95.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $2.21 million (Q3 2025), $4.85 million (Q2 2025) and $6.14 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 84.97 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 85.49 Bn |
| 10 | BioRestorative Therapies | 687,973.67 | -23.25 Mn | 17,964.00 | 356,744.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 356,744.00 |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 4.85 Mn |
| Mar 31, 2025 | 6.14 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 9.99 Mn |
| Jun 30, 2024 | 10.80 Mn |
| Mar 31, 2024 | 14.50 Mn |
| Dec 31, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.76 Mn |
| Jun 30, 2023 | 2.64 Mn |
| Mar 31, 2023 | 6.46 Mn |
| Dec 31, 2022 | 10.29 Mn |
| Sep 30, 2022 | 9.78 Mn |
| Jun 30, 2022 | 12.16 Mn |
| Mar 31, 2022 | 5.95 Mn |
| Dec 31, 2021 | 10.78 Mn |
| Sep 30, 2021 | -4.88 Mn |
| Jun 30, 2021 | -3.81 Mn |
| Mar 31, 2021 | -2.69 Mn |
API Access
BioRestorative Therapies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=BRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "BRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=BRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();